HOME › DRUGS › DAPAGLIFLOZIN, SAXAGLIPTIN MONOHYDRATE
ACTIVE SUBSTANCE / INN

DAPAGLIFLOZIN, SAXAGLIPTIN MONOHYDRATE

Brand name(s): DAPAGLIFLOZIN AND SAXAGLIPTIN MONOHYDRATE
FDA LISTED
NONE (TENTATIVE APPROVAL)
ANDA211532
ACTIVE SUBSTANCE
Dapagliflozin, Saxagliptin Monohydrate
REGULATORS
FDA
SPONSORS / MAH
LUPIN LTD
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
DAPAGLIFLOZIN AND SAXAGLIPTIN MONOHYDRATEANDA211532LUPIN LTDNone (Tentative Approval)

FULL INTELLIGENCE ON DAPAGLIFLOZIN, SAXAGLIPTIN MONOHYDRATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →